Memantine vs Tofacitinib
Memantine vs Tofacitinib: Overview
This comparison examines the pharmacological differences between Memantine and Tofacitinib.
Mechanism of Action
Memantine: Non-competitive NMDA receptor antagonist.
Tofacitinib: Pan-JAK inhibitor with preference for JAK1 and JAK3 blocking pro-inflammatory cytokine signaling.
Pharmacokinetics
Half-life: Memantine β 60-80 hours; Tofacitinib β 3.2 hours.
Chemical Properties
Molecular Formula: Memantine β C12H21N; Tofacitinib β C16H20N6O.
Molecular Weight: Memantine β 179.3080 g/mol; Tofacitinib β 312.3700 g/mol.
Type: Memantine β Small molecule; Tofacitinib β Small molecule.